We use cookies for a better user experience. Read our Privacy Policy
I Agree
Biopharmaceutical Fermentation Systems Market
Global Biopharmaceutical Fermentation Systems Market: Snapshot
Growing geriatric population rise in inescapability of wearisome diseases over the world, and flood in human administrations utilization drive enthusiasm for biopharmaceuticals. This along these lines is likely going to fuel the advancement of the global biopharmaceutical fermentation systems market during the gauge time period. A couple of pharmaceutical associations are busy with inventive work of creative new plans and characteristic drugs to meet the dismissed accommodating needs. For instance, Biocon, India's greatest, improvement drove, totally fused biopharmaceutical association which positions among top three biosimilars overall players for insulin, has advocated the rh-insulin (recombinant human insulin) through Pichia development advancement. This is the central point that supports the development of global biopharmaceutical fermentation systems market in coming years.
Global Biopharmaceutical Fermentation Systems Market: Overview
Fermentation plays a crucial role in the development new drugs. These drugs can help the patients’ in curing diseases like cancer, H1NI viruses and many other epidemic diseases. The demand for developing new drugs has driven the global biopharmaceutical fermentation systems market from 2018 to 2026. The growth of the market is also attributed to the increasing cases of diseases influenza and typhopoid that are caused by viruses. Moreover, the emergence of several unknown viruses requires effective vaccines, the development of these vaccines is also a major factor that propels the growth of global biopharmaceutical fermentation systems market from 2018 to 2026.
The report by Transparency Market research states that the global biopharmaceutical fermentation systems market shall witness a significant growth during the forecast period. According to the report the market is projected to witness a substantial 6.0% CAGR from 2018 to 2026. Moreover the report also states that the market shall reach to the value of US$ 17.6 bn by the end of the duration. The report also cover various facets such as developments, challenges, trends, drivers, and opportunities that are prevalent in global biopharmaceutical fermentation systems market from 2018 to 2026.
As per the report the global biopharmaceutical fermentation systems market is highly fragmented and competitive. This is because the market has some prominent players that are driving the dynamics of global biopharmaceutical fermentation systems market. These players have total control over the market and have significant hold over the global biopharmaceutical fermentation systems market.
Global Biopharmaceutical Fermentation Systems Market: Trends and Drivers
Increasing Incidences of Chronic Diseases
Increment in geriatric populace, ascend in pervasiveness of interminable illnesses over the world, and flood in human services consumption drive interest for biopharmaceuticals. This thusly is probably going to fuel the development of the global biopharmaceutical fermentation systems market during the estimate time frame. A few pharmaceutical organizations are occupied with innovative work of imaginative new plans and natural medications to meet the neglected helpful needs. For example, Biocon, India's biggest, development drove, completely incorporated biopharmaceutical organization which positions among top three biosimilar worldwide players for insulin, has popularized the rh-insulin (recombinant human insulin) through Pichia maturation innovation. This is the major factor that boosts the growth of global biopharmaceutical fermentation systems market from 2018 to 2026.
Global Biopharmaceutical Fermentation Systems Market: Segmentation
On the basis of application, the recombinant proteins segment dominated the global biopharmaceutical fermentation systems market. High dependence on microbial frameworks for recombinant protein creation contributed toward the main portion of the section. Increment in interest in look into exercises and presentation of new protein therapeutics have fundamentally added to the improvement of recombinant remedial antibodies and proteins. Also, ascend in the quantity of clinical preliminaries in the pharmaceutical business have helped the fragment in recent years. The recombinant proteins fragment is required to overwhelm the market during the figure time frame, attributable to an expanded spotlight on creating imaginative combination protein and immune response tranquilize conjugates items.
Global Biopharmaceutical Fermentation Systems Market: Regional Analysis
The global biopharmaceutical fermentation systems market is dominated by North America and Europe. This is because of the development of new pharmaceutical companies and improving healthcare sector in U.S. and U.K. This is the reason that these regions are dominating the regional front of global biopharmaceutical fermentation systems market from 2018 to 2026.
The global biopharmaceutical fermentation systems market has been segmented as follows:
|
Product |
|
|
Application |
|
|
End-user |
|
|
Geography |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Biopharmaceutical Fermentation Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Key Trends
4.4. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Market Outlook
5.1. Price Comparison Analysis (2017)
5.1.1. By Product
5.1.2. By Region
5.2. Key Potential Customers
5.2.1. Key Potential Customers by Region
5.3. Key Distributor Analysis
5.4. Bioprocess Analyzers Segment Analysis & Overview
5.5.Technological Advancements
5.6.Key Mergers & Acquisitions
6. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2016–2026
6.3.1. Upstream Products
6.3.1.1. Bioreactors/Fermenters
6.3.1.2. Bioprocess Analyzers
6.3.1.3. Process Monitoring Systems
6.3.1.4. Media & Culture Preparation
6.3.1.5. Culture Media, Buffers & Inducers
6.3.1.6. Other Upstream Products
6.3.2. Downstream Products
6.3.2.1. Filtration & Separation
6.3.2.2. Chromatography
6.3.2.3. Consumables & Accessories
6.3.2.4. Other Downstream Products
6.4. Market Attractiveness, by Product
7. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2016–2026
7.3.1. Antibiotics
7.3.2. Monoclonal Antibodies
7.3.3. Recombinant Proteins
7.3.4. Probiotics
7.3.5. Others
7.4. Market Attractiveness, by Application
8. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by End-users
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-User, 2016–2026
8.3.1. Biopharmaceutical Companies
8.3.2. Contract Manufacturing Organizations
8.3.3. Contract Research Organizations
8.3.4. Academic Research Institutes
8.3.5. Food Industry
8.3.6. Others
8.4. Market Attractiveness, by End-User
9. Global Biopharmaceutical Fermentation Systems Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness, by Region
10. North America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2016–2026
10.2.1. Upstream Products
10.2.1.1. Bioreactors/Fermenters
10.2.1.2. Bioprocess Analyzers
10.2.1.3. Process Monitoring Systems
10.2.1.4. Media & Culture Preparation
10.2.1.5. Culture Media, Buffers & Inducers
10.2.1.6. Other Upstream Products
10.2.2. Downstream Products
10.2.2.1. Filtration & Separation
10.2.2.2. Chromatography
10.2.2.3. Consumables & Accessories
10.2.2.4. Other Downstream Products
10.3. Market Value Forecast, by Application, 2016–2026
10.3.1. Antibiotics
10.3.2. Monoclonal Antibodies
10.3.3. Recombinant Proteins
10.3.4. Probiotics
10.3.5. Others
10.4. Market Value Forecast, by End-users, 2016–2026
10.4.1. Biopharmaceutical Companies
10.4.2. Contract Manufacturing Organizations
10.4.3. Contract Research Organizations
10.4.4. Academic Research Institutes
10.4.5. Food Industry
10.4.6. Others
10.5. Market Value Forecast, by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Biopharmaceutical Fermentation Systems Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product, 2016–2026
11.2.1. Upstream Products
11.2.1.1. Bioreactors Fermenters
11.2.1.2. Bioprocess Analyzers
11.2.1.3. Process Monitoring Systems
11.2.1.4. Media & Culture Preparation
11.2.1.5. Culture Media, Buffers & Inducers
11.2.1.6. Other Upstream Products
11.2.2. Downstream Products
11.2.2.1. Filtration & Separation
11.2.2.2. Chromatography
11.2.2.3. Consumables & Accessories
11.2.2.4. Other Downstream Products
11.3.Market Value Forecast, by Application, 2016–2026
11.3.1. Antibiotics
11.3.2. Monoclonal Antibodies
11.3.3. Recombinant Proteins
11.3.4. Probiotics
11.3.5. Others
11.4.Market Value Forecast, by End-users, 2016–2026
11.4.1. Biopharmaceutical Companies
11.4.2. Contract Manufacturing Organizations
11.4.3. Contract Research Organizations
11.4.4. Academic Research Institutes
11.4.5. Food Industry
11.4.6. Others
11.5.Market Value Forecast, by Country, 2016–2026
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-users
11.6.4. By Country
12. Asia Pacific Biopharmaceutical Fermentation Systems Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product, 2016–2026
12.2.1. Upstream Products
12.2.1.1. Bioreactors/Fermenters
12.2.1.2. Bioprocess Analyzers
12.2.1.3. Process Monitoring Systems
12.2.1.4. Media & Culture Preparation
12.2.1.5. Culture Media, Buffers & Inducers
12.2.1.6. Other Upstream Products
12.2.2. Downstream Products
12.2.2.1. Filtration & Separation
12.2.2.2. Chromatography
12.2.2.3. Consumables & Accessories
12.2.2.4. Other Downstream Products
12.3.Market Value Forecast, by Application, 2016–2026
12.3.1. Antibiotics
12.3.2. Monoclonal Antibodies
12.3.3. Recombinant Proteins
12.3.4. Probiotics
12.3.5. Others
12.4.Market Value Forecast, by End-users, 2016–2026
12.4.1. Biopharmaceutical Companies
12.4.2. Contract Manufacturing Organizations
12.4.3. Contract Research Organizations
12.4.4. Academic Research Institutes
12.4.5. Food Industry
12.4.6. Others
12.5.Market Value Forecast, by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6.Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-users
12.6.4. By Country
13. Latin America Biopharmaceutical Fermentation Systems Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product, 2016–2026
13.2.1. Upstream Products
13.2.1.1. Bioreactors/Fermenters
13.2.1.2. Bioprocess Analyzers
13.2.1.3. Process Monitoring Systems
13.2.1.4. Media & Culture Preparation
13.2.1.5. Culture Media, Buffers & Inducers
13.2.1.6. Other Upstream Products
13.2.2. Downstream Products
13.2.2.1. Filtration & Separation
13.2.2.2. Chromatography
13.2.2.3. Consumables & Accessories
13.2.2.4. Other Downstream Products
13.3.Market Value Forecast, by Application, 2016–2026
13.3.1. Antibiotics
13.3.2. Monoclonal Antibodies
13.3.3. Recombinant Proteins
13.3.4. Probiotics
13.3.5. Others
13.4.Market Value Forecast, by End-users, 2016–2026
13.4.1. Biopharmaceutical Companies
13.4.2. Contract Manufacturing Organizations
13.4.3. Contract Research Organizations
13.4.4. Academic Research Institutes
13.4.5. Food Industry
13.4.6. Others
13.5.Market Value Forecast, by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6.Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-Users
13.6.4. By Country
14. Middle East & Africa Biopharmaceutical Fermentation Systems Market Analysis and Forecast
14.1.Introduction
14.1.1. Key Findings
14.2.Market Value Forecast, by Product, 2016–2026
14.2.1. Upstream Products
14.2.1.1. Bioreactors/Fermenters
14.2.1.2. Bioprocess Analyzers
14.2.1.3. Process Monitoring Systems
14.2.1.4. Media & Culture Preparation
14.2.1.5. Culture Media, Buffers & Inducers
14.2.1.6. Other Upstream Products
14.2.2. Downstream Products
14.2.2.1. Filtration & Separation
14.2.2.2. Chromatography
14.2.2.3. Consumables & Accessories
14.2.2.4. Other Downstream Products
14.3.Market Value Forecast, by Application, 2016–2026
14.3.1. Antibiotics
14.3.2. Monoclonal Antibodies
14.3.3. Recombinant Proteins
14.3.4. Probiotics
14.3.5. Others
14.4.Market Value Forecast, by End-users, 2016–2026
14.4.1. Biopharmaceutical Companies
14.4.2. Contract Manufacturing Organizations
14.4.3. Contract Research Organizations
14.4.4. Academic Research Institutes
14.4.5. Food Industry
14.4.6. Others
14.5.Market Value Forecast, by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6.Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-users
14.6.4. By Country
15. Competition Landscape
15.1.Market Player – Competition Matrix (By Tier and Size of Companies)
15.2.Market Share Analysis, by Company (2016)
15.3.Market Footprint Analysis
15.3.1. By Region
15.3.2. By Product
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. GE Healthcare
15.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.1.2. Company Financials
15.5.1.3. Growth Strategies
15.5.1.4. Recent Events
15.5.1.5. SWOT Analysis
15.5.2. Thermo Fisher Scientific Inc.
15.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.2.2. Company Financials
15.5.2.3. Growth Strategies
15.5.2.4. Recent Events
15.5.2.5. SWOT Analysis
15.5.3. Danaher Corporation
15.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.3.2. Company Financials
15.5.3.3. Growth Strategies
15.5.3.4. Recent Events
15.5.3.5. SWOT Analysis
15.5.4. Sartorius Stedim Biotech
15.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.4.2. Company Financials
15.5.4.3. Growth Strategies
15.5.4.4. Recent Events
15.5.4.5. SWOT Analysis
15.5.5. Merck KGaA
15.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.5.2. Company Financials
15.5.5.3. Growth Strategies
15.5.5.4. Recent Events
15.5.5.5. SWOT Analysis
15.5.6. Eppendorf AG
15.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.6.2. Company Financials
15.5.6.3. Growth Strategies
15.5.6.4. Recent Events
15.5.6.5. SWOT Analysis
15.5.7. F. Hoffmann-La Roche Ltd.
15.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.7.2. Company Financials
15.5.7.3. Growth Strategies
15.5.7.4. Recent Events
15.5.7.5. SWOT Analysis
15.5.8. Nova Biomedicals
15.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.8.2. Growth Strategies
15.5.8.3. Recent Events
15.5.8.4. SWOT Analysis
15.5.9. Lonza
15.5.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.9.2. Company Financials
15.5.9.3. Growth Strategies
15.5.9.4. Recent Events
15.5.9.5. SWOT Analysis
15.5.10. Becton, Dickinson and Company
15.5.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.5.10.2. Company Financials
15.5.10.3. Growth Strategies
15.5.10.4. Recent Events
15.5.10.5. SWOT Analysis
List of Tables
Table 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 02: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 03: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 05: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) & Volume (Units) Forecast, by End-user, 2016–2026
Table 06: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 08: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
Table 09: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
Table 10: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 11: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 12: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 13: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 14: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Product, 2016–2026
Table 15: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Product, 2016–2026
Table 16: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 17: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 18: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 19: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 20: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 21: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 22: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 23: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 24: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 26: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 27: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 28: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 29: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 30: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 31: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 32: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Upstream Products, 2016–2026
Table 33: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Downstream Products, 2016–2026
Table 34: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 35: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by End-user, 2016–2026
Table 36: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
List of Figures
Figure 01: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) and Distribution, by Region, 2017 and 2026
Figure 02: Global Biopharmaceutical Fermentation Systems
Figure 03: Top Three Trends
Figure 04: Global Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 05: Global Market Value Share, by Product (2017)
Figure 06: Global Market Value Share, by Application (2017)
Figure 07: Global Market Value Share, by End-user (2017)
Figure 08: Global Market Value Share, by Region (2017)
Figure 09: Global Biopharmaceutical Fermentation System Market, by Key Customers and Region (2017)
Figure 10: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 11: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
Figure 12: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, Downstream Products, 2017 and 2026
Figure 13: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioreactors/Fermenters, 2016–2026
Figure 14: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Bioprocess Analyzers, 2016–2026
Figure 15: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Monitoring Devices, 2016–2026
Figure 16: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Media & Culture Preparation, 2016–2026
Figure 17: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Culture Media, Buffers & Inducers, 2016–2026
Figure 18: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
Figure 19: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Filtration & Separation, 2016–2026
Figure 20: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Chromatography, 2016–2026
Figure 21: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Consumables & Accessories, 2016–2026
Figure 22: Global Biopharmaceutical Fermentation Systems Market Revenue (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
Figure 23: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
Figure 24: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
Figure 25: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 26: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Antibiotics, 2016–2026
Figure 27: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Monoclonal Antibodies, 2016–2026
Figure 28: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Recombinant Proteins, 2016–2026
Figure 29: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Probiotics, 2016–2026
Figure 30: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 31: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
Figure 32: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 33: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biopharmaceutical Companies, 2016–2026
Figure 34: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CMOs, 2016–2026
Figure 35: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by CDOs, 2016–2026
Figure 36: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic Research Institutes, 2016–2026
Figure 37: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Food Industry, 2016–2026
Figure 38: Global Biopharmaceutical Fermentation Systems Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 39: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 40: Global Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Region, 2017 and 2026
Figure 41: Global Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Region, 2018–2026
Figure 42: North America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 43: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 44: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
Figure 45: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
Figure 46: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
Figure 47: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
Figure 48: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 49: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
Figure 50: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 51: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 52: North America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country, 2017 and 2026
Figure 53: North America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country, 2018–2026
Figure 54: Europe Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 55: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 56: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Product, 2017 and 2026
Figure 57: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Product, 2018 - 2026
Figure 58: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Product, 2017 and 2026
Figure 59: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Product, 2018 - 2026
Figure 60: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 61: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018 -2026
Figure 62: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 63: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 64: Europe Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 65: Europe Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 66: Asia Pacific Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 67: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 68: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
Figure 69: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
Figure 70: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
Figure 71: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018– 2026
Figure 72: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 73: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
Figure 74: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 75: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 76: Asia Pacific Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 77: Asia Pacific Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 78: Latin America Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 79: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 80: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
Figure 81: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
Figure 82: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
Figure 83: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
Figure 84: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 85: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
Figure 86: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 87: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 88: Latin America Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 89: Latin America Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 90: Middle East & Africa Biopharmaceutical Fermentation Systems Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 91: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Product, 2017 and 2026
Figure 92: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Upstream Products, 2017 and 2026
Figure 93: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Upstream Products, 2018–2026
Figure 94: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Downstream Products, 2017 and 2026
Figure 95: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Downstream Products, 2018–2026
Figure 96: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Application, 2017 and 2026
Figure 97: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Application, 2018–2026
Figure 98: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by End-user, 2017 and 2026
Figure 99: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by End-user, 2018–2026
Figure 100: Middle East & Africa Biopharmaceutical Fermentation Systems Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 101: Middle East & Africa Biopharmaceutical Fermentation Systems Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 101: Market Footprint Analysis, by Product (Upstream Products)
Figure 102: Market Footprint Analysis, by Product (Downstream Products)
Figure 103: Global Biopharmaceutical Fermentation Systems Market Share, by Company, 2017
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes